Acclimatization to high altitude is essential for the prevention of high-altitude illnesses such as acute mountain sickness (AMS), or lifethreatening high-altitude cerebral and pulmonary oedemas, but also for the partial restoration of the initial loss of (submaximal) exercise performance during acute exposure to high altitude. Acclimatization represents a complex process including several physiological and molecular mechanisms of different time courses (Mallet et al., 2023).Improvement of blood oxygenation and oxygen delivery to tissues constitute the primary goal of acclimatization, which is achieved to a large extent by increased pulmonary ventilation (ventilatory acclimatization to hypoxia, VAH). In this issue of Experimental Physiology, Isakovich et al. present an intriguing approach on how to assess the individual VAH status during high-altitude ascent (Isakovich et al.,
2024).While VAH is almost completed within an about 8-day sojourn to altitudes between 4000 and 4500 m, more than 2 months may be necessary when ascending to extreme altitudes, that is, above 8000 m (West, 1988). When sea-level or low-altitude residents ascend to high altitude, pulmonary ventilation progressively increases with hypoxic stimulation of peripheral chemoreceptors (in the carotid bodies) preventing a greater fall of blood oxygen content and associated severe hypoxemia. According to the alveolar gas equation, hyperventilation is paralleled by an increase in the alveolar partial pressure of oxygen (P AO 2 ) and a related decrease in the alveolar partial pressure of carbon dioxide (P ACO 2 ).